PD
IRWD icon

Point72 (DIFC)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Point72 (DIFC)’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.73K Buy
+3,611
New +$3.74K ﹤0.01% 1010
2025
Q2 		– Sell
-41,701
Closed -$61.3K – 1834
2025
Q1 		$61.3K Buy
41,701
+40,543
+3,501% +$96.6K ﹤0.01% 1169
2024
Q4 		$5.13K Buy
+1,158
New +$4.7K ﹤0.01% 1390
2024
Q2 		– Sell
-41,918
Closed -$365K – 1677
2024
Q1 		$365K Buy
+41,918
New +$509K 0.01% 824

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Point72 (DIFC)'s IRWD Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Ironwood Pharmaceuticals (IRWD) in Q3 2025: 3,611 shares worth $4.73K. The stake represents ﹤0.01% of the portfolio and ranks #1010 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in IRWD as recently as Q1 2025.

Point72 (DIFC) first reported a position in IRWD in Q1 2024 and has held it in 4 quarters since. The position peaked at $365K in Q1 2024. 166 funds tracked by Wall St. Rank hold IRWD as of Q3 2025.

  • Point72 (DIFC) held 3,611 shares of Ironwood Pharmaceuticals worth $4.73K as of Q3 2025.
  • Ironwood Pharmaceuticals was a new Point72 (DIFC) position in Q3 2025.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #1010 holding.
  • Point72 (DIFC) first reported a position in Ironwood Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • Point72 (DIFC)'s Ironwood Pharmaceuticals position peaked at $365K in Q1 2024.
  • 166 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.